<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Thu, 23 Apr 2026 01:56:07 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/immunospuppressive/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Cannabinoid Receptor Type 2 Stimulation Treats COVID-19]]></title><description><![CDATA[Agonists of the cannabinoid type 2 receptor (CBR2), like ∆9THC, the novel ∆9-THCP, and the synthetic HU910, HU308 and JWH133, bind to the CBR2 to treat COVID-19 through immunopsuppression and reduction]]></description><link>http://direct.ecency.com/hive-195708/@medikatie/cannabinoid-receptor-type-2-stimulation-treats-covid-19</link><guid isPermaLink="true">http://direct.ecency.com/hive-195708/@medikatie/cannabinoid-receptor-type-2-stimulation-treats-covid-19</guid><category><![CDATA[hive-195708]]></category><dc:creator><![CDATA[medikatie]]></dc:creator><pubDate>Tue, 02 Jun 2020 07:52:33 GMT</pubDate><enclosure url="https://images.ecency.com/p/HNWT6DgoBc1692QWn5trsLBYecSp3jKD1kzdmSDbhTciDMuPAfvic1sdSBNeu5w8qCGUXThBRrZkBFYgM2ZokESu5oVfhRKRLrAagxPSHzAGLYowiBTYPRGGTLi?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>